Key result
β-Hydroxybutyrate significantly restored doxorubicin-induced left ventricular dysfunction and partially prevented adverse cardiac remodeling by inhibiting cell apoptosis and oxidative stress.
Why the study?
Doxorubicin is limited by serious irreversible cardiotoxicity, and whether beta-hydroxybutyrate can protect against doxorubicin-induced cardiotoxicity remains unknown.
Does β-Hydroxybutyrate prevent doxorubicin-induced cardiotoxicity in mice and cardiomyocytes?
Does β-Hydroxybutyrate prevent doxorubicin-induced cardiotoxicity in mice and cardiomyocytes?
BHB protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress and apoptosis, highlighting its potential as a cardioprotective metabolite.
Answers are grounded in this paper and cite their sources.
BHB may attenuate doxorubicin cardiotoxicity in mice; leaves open translation to human cardioprotection.
Background: β-Hydroxybutyrate (BHB) is produced by fatty acid oxidation in the liver under the fasting state and confirmed to play a cardioprotective role in ischemia and hypertensive settings. Doxorubicin (DOX) is an effective chemotherapeutic drug, but limited by serious irreversible cardiotoxicity. However, whether BHB can protect from DOX-induced cardiotoxicity remains unknown. Methods and Results: C57BL/6 mice were intraperitoneally injected with DOX to induce cardiac toxicity and intragastrically administered into BHB for treatment. They were randomly divided into three groups, namely a sham group (Sham), a doxorubicin group (DOX), and a doxorubicin+β-Hydroxybutyrate group (DOX + BHB). Echocardiography and pathological staining were performed to evaluate cardiac function and fibrosis. H9c2 cardiomyocyte was treated with DOX or BHB for in vitro experiments. Cell apoptosis and ROS were determined by flow cytometry. BHB significantly restored DOX-induced cardiac function decline and partially prevented cardiac reverse remodeling, characterized by increased cell size and decreased fibrosis. In vitro , BHB treatment decreased cellular injury and apoptosis. Also, BHB alleviated oxidative stress level and increased mitochondrial membrane potential. Conclusion: Our results suggested that BHB could protected from DOX-induced cardiotoxicity by inhibiting cell apoptosis and oxidative stress and maintaining mitochondrial membrane integrity.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2021) studied Doxorubicin-induced cardiotoxicity (n=18). β-Hydroxybutyrate vs. Doxorubicin alone was evaluated on Ejection fraction (EF) (p=<0.01). β-Hydroxybutyrate significantly restored doxorubicin-induced left ventricular dysfunction and partially prevented adverse cardiac remodeling by inhibiting cell apoptosis and oxidative stress.
Synapse has enriched 10 related papers. Consider them for comparative context: